Profile data is unavailable for this security.
About the company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
- Revenue in USD (TTM)92.37bn
- Net income in USD25.42bn
- LocationPfizer Inc235 E 42ND STNEW YORK 10017-5703United StatesUSA
- Phone+1 (212) 573-2323
- Fax+1 (302) 655-5049
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|PFE:NYQ since |
|Biohaven Pharmaceutical Holding Co Ltd||Announced||10 May 2022||10 May 2022Announced||10.83%||12.60bn|
|ReViral Ltd||Announced||07 Apr 2022||07 Apr 2022Announced||1.97%||525.00m|
|Arena Pharmaceuticals Inc||Deal completed||13 Dec 2021||13 Dec 2021Deal completed||2.14%||6.68bn|
|Trillium Therapeutics Inc||Deal completed||23 Aug 2021||23 Aug 2021Deal completed||10.65%||2.21bn|